Prospective observational study of plasma ghrelin concentration after hematopoietic stem cell transplantation.

Prospective observational study of plasma ghrelin concentration after hematopoietic stem cell transplantation. - Ghrelin after HCT

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000046801

Enrollment

Registered

2022-02-01

Start date

2022-02-02

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hematopoietic stem cell transplantation

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: 1.Patients scheduled for allogeneic or autologous hematopoietic stem cell transplantation 2.20 years and over 3.ECOG performance status 0 1 2 4.Patients with written consent

Exclusion criteria

Exclusion criteria: 1.Patients who have difficulty communicating 2.Patients who have difficulty eating 3.Patients who have active disorder of digestive system 4.Pregnant patient 5.Patients with dementia and severe mental illness 6.Patients who underwent total gastrectomy 7.Patients that the attending physician deems ineligible

Design outcomes

Primary

Measure	Time frame
Change of plasma ghrelin concentration after hematopoietic stem cell transplantation	—

Countries

Japan

Contacts

Public ContactTSUTOMU TAKAHASHI

Faculty of Medicine, Shimane University Department of 3rd internal medicine

ben2106t@med.shimane-u.ac.jp0853-20-2198

Outcome results